Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Pro-Lyte .86 % Powder For Solution is a Health Canada–registered veterinary drug (DIN 00766321) held by Quali-Tech Inc., containing Sodium Phosphate Monobasic. Health Canada lists its status as Cancelled Post Market (status date 20 Feb 1997). Nexara Health has matched 11 registrations of Sodium Phosphate Monobasic across 2 other regulated markets.

Health Canada registration

DIN00766321
Brand namePro-Lyte
Active ingredientSodium Phosphate Monobasic
Strength.86 %
Dosage formPowder For Solution
RouteOral
CompanyQuali-Tech Inc.
StatusCancelled Post Market — 20 Feb 1997
ClassVeterinary
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Sodium Phosphate Monobasic registered in other markets

11 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
Taiwan"Henton" Enema健康化學製藥股份有限公司外用液劑已註銷TFDA
TaiwanEvac Enema健康化學製藥股份有限公司外用液劑RegisteredTFDA
TaiwanI-131 Sodium Iodide Diagnostic CapsulesInstitut National Des Radioelements "Ire"膠囊劑已註銷TFDA
TaiwanIsdar Solution明德製藥股份有限公司內服液劑RegisteredTFDA
TaiwanKenko Enema健康化學製藥股份有限公司外用液劑已註銷TFDA
TaiwanRiko Enema健康化學製藥股份有限公司外用液劑RegisteredTFDA
United StatesSodium phosphate monobasicSionc Pharmaceuticals Pvt LtdPowderFDA NDC
United StatesSodium Phosphate Monobasic AnhydrousJost Chemical Co.GranuleFDA NDC
United StatesSodium Phosphate Monobasic MonohydrateAvantor Performance Materials, LLCCrystalFDA NDC
United StatesSodium Phosphate Monobasic MonohydrateJost Chemical Co.GranuleFDA NDC
United StatesSodium Phosphate Monobasic MonohydrateAvantor Performance Materials, LLCPowderFDA NDC

See every manufacturer of Sodium Phosphate Monobasic worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Pro-Lyte (DIN 00766321) marketed in Canada?

No. Health Canada lists DIN 00766321 as Cancelled Post Market as of 20 Feb 1997.

Who holds the Canadian licence for this product?

Quali-Tech Inc. is the company of record in the Health Canada Drug Product Database.

Is Sodium Phosphate Monobasic registered outside Canada?

Yes — Nexara Health has matched 11 registrations in 2 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 00766321, status date 1997-02-20; national medicine registries: FDA NDC, TFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 00766321, status date 1997-02-20; national medicine registries: FDA NDC, TFDA.

Health Canada Drug Product Database (DPD), DIN 00766321, status date 1997-02-20; national medicine registries: FDA NDC, TFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.